Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec 2;6(1):26.
doi: 10.1186/s40345-018-0135-7.

Lithium during pregnancy and after delivery: a review

Affiliations
Review

Lithium during pregnancy and after delivery: a review

Eline M P Poels et al. Int J Bipolar Disord. .

Abstract

Lithium is an effective treatment in pregnancy and postpartum for the prevention of relapse in bipolar disorder. However, lithium has also been associated with risks during pregnancy for both the mother and the unborn child. Recent large studies have confirmed the association between first trimester lithium exposure and an increased risk of congenital malformations. Importantly, the risk estimates from these studies are lower than previously reported. Tapering of lithium during the first trimester could be considered but should be weighed against the risks of relapse. There seems to be no association between lithium use and pregnancy or delivery related outcomes, but more research is needed to be more conclusive. When lithium is prescribed during pregnancy, lithium blood levels should be monitored more frequently than outside of pregnancy and preferably weekly in the third trimester. We recommend a high-resolution ultrasound with fetal anomaly scanning at 20 weeks. Ideally, delivery should take place in a specialised hospital where psychiatric and obstetric care for the mother is provided and neonatal evaluation and monitoring of the child can take place immediately after birth. When lithium is discontinued during pregnancy, lithium could be restarted immediately after delivery as strategy for relapse prevention postpartum. Given the very high risk of relapse in the postpartum period, a high target therapeutic lithium level is recommended. Most clinical guidelines discourage breastfeeding in women treated with lithium. It is highly important that clinicians inform and advise women about the risks and benefits of remaining on lithium in pregnancy, if possible preconceptionally. In this narrative review we provide an up-to-date overview of the literature on lithium use during pregnancy and after delivery leading to clinical recommendations.

Keywords: Bipolar disorder; Breastfeeding; Congenital malformations; Delivery; Lithium; Neurodevelopment; Perinatal; Postpartum psychosis; Pregnancy; Review.

PubMed Disclaimer

References

    1. Ang MS, Thorp JA, Parisi VM. Maternal lithium therapy and polyhydramnios. Obstet Gynecol. 1990;76(3 Pt 2):517–519. - PubMed
    1. Arnon RG, Marin-Garcia J, Peeden JN. Tricuspid valve regurgitation and lithium carbonate toxicity in a newborn infant. Am J Dis Child. 1981;135(10):941–943. - PubMed
    1. Austin MP. Puerperal affective psychosis: is there a case for lithium prophylaxis? Br J Psychiatry. 1992;161:692–694. doi: 10.1192/bjp.161.5.692. - DOI - PubMed
    1. Austin M-P, Highet N, Expert Working Group . Mental health care in the perinatal period: Australian clinical practice guideline. Melbourne: Centre of Perinatal Excellence; 2017.
    1. Barker DJP. The fetal and infant origins of adult disease. Br Med J. 1990;301(6761):1111. doi: 10.1136/bmj.301.6761.1111. - DOI - PMC - PubMed

LinkOut - more resources